Skip to main content
WP

www.plenaryai.com

PlenaryAI develops a real-time, AI-assisted quantitative assessment tool for molecular imaging that automates the identification, segmentation, and classification of tissue types, enhancing diagnostic accuracy for conditions like cancer and Parkinson's disease. By integrating machine learning with multi-modality imaging, the platform provides clinicians with precise biochemical insights, enabling tailored treatment plans based on individual patient data.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Manual analysis of molecular imaging data in clinical and research settings is time-consuming, expensive, and prone to inter-reader variability. This can lead to delays in diagnosis, inconsistent treatment decisions, and challenges in translating preclinical findings to clinical applications.

Solution

PlenaryAI offers AI-powered tools for quantitative assessment of molecular imaging, automating the identification, segmentation, and classification of tissue types. The platform integrates machine learning with multi-modality imaging data to provide clinicians with objective, real-time biochemical insights. This enables more accurate diagnoses, personalized treatment plans, and improved monitoring of treatment response. PlenaryAI's technology also facilitates the translation of promising new technologies from preclinical studies to clinical use.

Target Audience

The primary target audience includes medical imaging professionals, radiologists, and clinical researchers involved in the diagnosis, monitoring, and treatment of diseases such as cancer and Parkinson's disease.

Features

  • AI-assisted tissue identification, segmentation, and classification in molecular images
  • Automated characterization of malignant lesions on PET images
  • Machine learning for Parkinson’s disease subtyping based on symptoms and signs
  • Real-time biochemical information for detection, diagnosis, and therapy response assessment
  • Integration of multi-modality imaging data for comprehensive analysis
  • Objective and systematic image analysis to reduce reader variability
This profile is AI-generated and may contain inaccuracies.